Melanoma antigen genes 1 and 2 are differentially expressed in human gastric and cardial carcinomas

Paola Granelli, C. Siardi, F. Zennaro, M. Cattaneo, G. Malferrari, R. Buffa, P. Fociani, F. Fregoni, F. De Ruberto, G. Fichera, A. Peracchia, I. Biunno

Research output: Contribution to journalArticle

Abstract

Background: MAGE genes encode for tumor-rejection antigens and are expressed in tumors of different histologic types but not in normal tissues, with the exception of testis and placenta. The aim of this study was to evaluate the frequency of MAGE-1 and -2 expression in gastric and in cardial carcinomas; these conditions have been described as two distinct diseases, having different etiologies, epidemiologic patterns, and gene mutations. Methods: Two groups of patients were studied: patients with distal gastric carcinoma and patients with carcinoma of the cardia. A group of patients with intestinal metaplasia in the gastric mucosa and controls were also included. All of them underwent upper GI endoscopy. Paired biopsy specimens were taken for routine histology and for RNA extraction, to study the expression of MAGE-1 and -2 genes: Results: None of the intestinal metaplastic samples or controls expressed MAGE-1 and -2 at detectable levels. Whereas 40% of the gastric cancer patients expressed either MAGE-1 or -2, 26.6% transcribed both. In the cardial cancer group, 20% of the cases expressed at least one MAGE, and only 6.6% expressed both genes. These results might reinforce the concept that cancer of the cardia is a distinct neoplastic disease with regard to esophageal and gastric (distal) carcinomas. Conclusions: Here we show that MAGE gene expression occurs in advanced stages of gastric and cardial cancer and therefore appears to be a late event. This might point to a reconsideration of their potential role in cancer immunotherapy.

Original languageEnglish
Pages (from-to)528-533
Number of pages6
JournalScandinavian Journal of Gastroenterology
Volume35
Issue number5
Publication statusPublished - 2000

Fingerprint

Melanoma-Specific Antigens
Stomach
Carcinoma
Cardia
Genes
Stomach Neoplasms
Neoplasms
Metaplasia
Neoplasm Antigens
Gastric Mucosa
Immunotherapy
Placenta
Endoscopy
Testis
Histology
RNA
Biopsy
Gene Expression
Mutation

Keywords

  • Cardial carcinoma
  • Gastric carcinoma
  • Intestinal metaplasia
  • MAGE genes
  • Tumor-rejection antigens

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Granelli, P., Siardi, C., Zennaro, F., Cattaneo, M., Malferrari, G., Buffa, R., ... Biunno, I. (2000). Melanoma antigen genes 1 and 2 are differentially expressed in human gastric and cardial carcinomas. Scandinavian Journal of Gastroenterology, 35(5), 528-533.

Melanoma antigen genes 1 and 2 are differentially expressed in human gastric and cardial carcinomas. / Granelli, Paola; Siardi, C.; Zennaro, F.; Cattaneo, M.; Malferrari, G.; Buffa, R.; Fociani, P.; Fregoni, F.; De Ruberto, F.; Fichera, G.; Peracchia, A.; Biunno, I.

In: Scandinavian Journal of Gastroenterology, Vol. 35, No. 5, 2000, p. 528-533.

Research output: Contribution to journalArticle

Granelli, P, Siardi, C, Zennaro, F, Cattaneo, M, Malferrari, G, Buffa, R, Fociani, P, Fregoni, F, De Ruberto, F, Fichera, G, Peracchia, A & Biunno, I 2000, 'Melanoma antigen genes 1 and 2 are differentially expressed in human gastric and cardial carcinomas', Scandinavian Journal of Gastroenterology, vol. 35, no. 5, pp. 528-533.
Granelli, Paola ; Siardi, C. ; Zennaro, F. ; Cattaneo, M. ; Malferrari, G. ; Buffa, R. ; Fociani, P. ; Fregoni, F. ; De Ruberto, F. ; Fichera, G. ; Peracchia, A. ; Biunno, I. / Melanoma antigen genes 1 and 2 are differentially expressed in human gastric and cardial carcinomas. In: Scandinavian Journal of Gastroenterology. 2000 ; Vol. 35, No. 5. pp. 528-533.
@article{4e5a4d68dcdd4fe799523b9a3e4b8e4e,
title = "Melanoma antigen genes 1 and 2 are differentially expressed in human gastric and cardial carcinomas",
abstract = "Background: MAGE genes encode for tumor-rejection antigens and are expressed in tumors of different histologic types but not in normal tissues, with the exception of testis and placenta. The aim of this study was to evaluate the frequency of MAGE-1 and -2 expression in gastric and in cardial carcinomas; these conditions have been described as two distinct diseases, having different etiologies, epidemiologic patterns, and gene mutations. Methods: Two groups of patients were studied: patients with distal gastric carcinoma and patients with carcinoma of the cardia. A group of patients with intestinal metaplasia in the gastric mucosa and controls were also included. All of them underwent upper GI endoscopy. Paired biopsy specimens were taken for routine histology and for RNA extraction, to study the expression of MAGE-1 and -2 genes: Results: None of the intestinal metaplastic samples or controls expressed MAGE-1 and -2 at detectable levels. Whereas 40{\%} of the gastric cancer patients expressed either MAGE-1 or -2, 26.6{\%} transcribed both. In the cardial cancer group, 20{\%} of the cases expressed at least one MAGE, and only 6.6{\%} expressed both genes. These results might reinforce the concept that cancer of the cardia is a distinct neoplastic disease with regard to esophageal and gastric (distal) carcinomas. Conclusions: Here we show that MAGE gene expression occurs in advanced stages of gastric and cardial cancer and therefore appears to be a late event. This might point to a reconsideration of their potential role in cancer immunotherapy.",
keywords = "Cardial carcinoma, Gastric carcinoma, Intestinal metaplasia, MAGE genes, Tumor-rejection antigens",
author = "Paola Granelli and C. Siardi and F. Zennaro and M. Cattaneo and G. Malferrari and R. Buffa and P. Fociani and F. Fregoni and {De Ruberto}, F. and G. Fichera and A. Peracchia and I. Biunno",
year = "2000",
language = "English",
volume = "35",
pages = "528--533",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Melanoma antigen genes 1 and 2 are differentially expressed in human gastric and cardial carcinomas

AU - Granelli, Paola

AU - Siardi, C.

AU - Zennaro, F.

AU - Cattaneo, M.

AU - Malferrari, G.

AU - Buffa, R.

AU - Fociani, P.

AU - Fregoni, F.

AU - De Ruberto, F.

AU - Fichera, G.

AU - Peracchia, A.

AU - Biunno, I.

PY - 2000

Y1 - 2000

N2 - Background: MAGE genes encode for tumor-rejection antigens and are expressed in tumors of different histologic types but not in normal tissues, with the exception of testis and placenta. The aim of this study was to evaluate the frequency of MAGE-1 and -2 expression in gastric and in cardial carcinomas; these conditions have been described as two distinct diseases, having different etiologies, epidemiologic patterns, and gene mutations. Methods: Two groups of patients were studied: patients with distal gastric carcinoma and patients with carcinoma of the cardia. A group of patients with intestinal metaplasia in the gastric mucosa and controls were also included. All of them underwent upper GI endoscopy. Paired biopsy specimens were taken for routine histology and for RNA extraction, to study the expression of MAGE-1 and -2 genes: Results: None of the intestinal metaplastic samples or controls expressed MAGE-1 and -2 at detectable levels. Whereas 40% of the gastric cancer patients expressed either MAGE-1 or -2, 26.6% transcribed both. In the cardial cancer group, 20% of the cases expressed at least one MAGE, and only 6.6% expressed both genes. These results might reinforce the concept that cancer of the cardia is a distinct neoplastic disease with regard to esophageal and gastric (distal) carcinomas. Conclusions: Here we show that MAGE gene expression occurs in advanced stages of gastric and cardial cancer and therefore appears to be a late event. This might point to a reconsideration of their potential role in cancer immunotherapy.

AB - Background: MAGE genes encode for tumor-rejection antigens and are expressed in tumors of different histologic types but not in normal tissues, with the exception of testis and placenta. The aim of this study was to evaluate the frequency of MAGE-1 and -2 expression in gastric and in cardial carcinomas; these conditions have been described as two distinct diseases, having different etiologies, epidemiologic patterns, and gene mutations. Methods: Two groups of patients were studied: patients with distal gastric carcinoma and patients with carcinoma of the cardia. A group of patients with intestinal metaplasia in the gastric mucosa and controls were also included. All of them underwent upper GI endoscopy. Paired biopsy specimens were taken for routine histology and for RNA extraction, to study the expression of MAGE-1 and -2 genes: Results: None of the intestinal metaplastic samples or controls expressed MAGE-1 and -2 at detectable levels. Whereas 40% of the gastric cancer patients expressed either MAGE-1 or -2, 26.6% transcribed both. In the cardial cancer group, 20% of the cases expressed at least one MAGE, and only 6.6% expressed both genes. These results might reinforce the concept that cancer of the cardia is a distinct neoplastic disease with regard to esophageal and gastric (distal) carcinomas. Conclusions: Here we show that MAGE gene expression occurs in advanced stages of gastric and cardial cancer and therefore appears to be a late event. This might point to a reconsideration of their potential role in cancer immunotherapy.

KW - Cardial carcinoma

KW - Gastric carcinoma

KW - Intestinal metaplasia

KW - MAGE genes

KW - Tumor-rejection antigens

UR - http://www.scopus.com/inward/record.url?scp=0034043348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034043348&partnerID=8YFLogxK

M3 - Article

C2 - 10868457

AN - SCOPUS:0034043348

VL - 35

SP - 528

EP - 533

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 5

ER -